Beiersdorf gains final approval for exclusive use of Nivea Blue as trademark

2019 ◽  
Vol 2019 (12) ◽  
pp. 7
Keyword(s):  
Final Approval

Kształtowanie się zasad dostępu do zasobów cyfrowych w Stanach Zjednoczonych w ramach zarządu powierniczego

2020 ◽  
Author(s):  
Arkadiusz Wudarski
Keyword(s):  
Electronic Communication ◽  
Social Issues ◽  
State Level ◽  
The United States ◽  
Legislative Process ◽  
Final Approval ◽  
State Laws ◽  
Uniform Law ◽  
To Receive ◽  
Digital Assets

This paper describes the development of the principles of fiduciary access to digital assets in the United States. It focuses on US legislation before the drafting of the Revised Uniform Fiduciary Access to Digital Assets Act (RUFADAA) in 2015, examining the legal and social issues faced by American lawyers in their search for a balance between facilitating fiduciary access and respecting privacy. Special attention is paid to the first legislative initiatives at the state level as well as to two model regulations that represent opposite approaches to access to digital assets: the Privacy Expectation Afterlife and Choices Act (PEAC) and the Uniform Fiduciary Access to Digital Assets Act (UFADAA). The analysis considers the requirements for gaining access to the account of a deceased user, conflicts between legally protected interests and conflicting federal and state laws, and the meaning of such legal terms as digital assets, fiduciary, custodian, content of an electronic communication, et. al. The reasons for the failure of these acts to receive final approval are also analysed. Research is based on American doctrine, state and federal legal acts, documentation of the legislative process, and the work of expert groups, including, primarily, the Uniform Law Commission (ULC).  

scholarly journals Planning Modes for Major Transportation Infrastructure Projects (MTIPs): Comparing China and Germany

2018 ◽  
Vol 10 (10) ◽  
pp. 3401 ◽  
Author(s):  
Tianxiao Zhou ◽  
Rong Tan ◽  
Thomas Sedlin
Keyword(s):  
Planning Process ◽  
Evaluation Criteria ◽  
Analytical Framework ◽  
Transportation Infrastructure ◽  
Final Approval ◽  
Infrastructure Projects ◽  
Policy Makers ◽  
Advantages And Disadvantages ◽  
Ex Post ◽  
Governance Practices

Because major transportation infrastructure projects (MTIPs) have significant effects for a sustainable development, the planning modes used for these projects have been a popular topic among scholars and policy makers. However, detailed descriptions and comparisons of planning modes in different countries are still rare. Therefore, this paper first provides a simple analytical framework based on the elements of the planning goal, the planning process, the planning result and the evaluation criteria. Focusing on the hierarchic mode adopted in China, and the democratic participatory mode adopted in Germany, the governance practices used in MTIP planning are clearly shown. Furthermore, by using two airport cases, this paper compares the differences between China and Germany in the realms of preparation, review, coordination, final approval, and planning performance. The main conclusions are: (1) The analytical approach presented in this paper provides an appropriate standard for describing and comparing planning modes for MTIPs; (2) the planning modes in the two countries each have advantages and disadvantages, reflecting the trade-off between ex ante and ex post costs; (3) the comparison between China and Germany may be instructive for both of these countries and for other countries in terms of improving their planning performance in the future.

Ceftobiprole: An Emerging Therapeutic Option for Resistant and Complicated Infections

2011 ◽  
Vol 3 ◽  
pp. CMT.S5032 ◽  
Author(s):  
Wanda C. Reygaert
Keyword(s):  
Antimicrobial Activity ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Therapeutic Option ◽  
Generation Cephalosporin ◽  
Final Approval ◽  
Cure Rate ◽  
Skin Structure ◽  
Fifth Generation ◽  
Complicated Skin ◽  
Mrsa Strains

Ceftobiprole is a new parenterally administered fifth generation cephalosporin which has been shown to have antimicrobial activity against a broad range of bacteria, and specifically against methicillin-resistant Staphylococcus aureus (MRSA) in complicated skin and skin structure infections (cSSSIs), with a cure rate non-inferior to vancomycin and ceftazidime. It has increased stability against β-lactamases and an increased affinity for PBP2’ in MRSA strains. Ceftobiprole has shown a low tendency to select for resistance, and because it is excreted mainly in the urine, a low potential for adverse drug interactions. It has been shown to cause few mild to moderate adverse effects in patients. The broad-spectrum of activity makes it an excellent choice for initial monotherapy in cSSSIs. There is also promise for use in all types of pneumonia, and synergistic possibilities with aminoglycoside and fluoroquinolone drugs. It is awaiting final approval by the FDA.

Barriers to phase I clinical trial protocol IRB approval at KCI

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 9080-9080
Author(s):  
D. Wang ◽  
E. Heath ◽  
A. Powell ◽  
T. Chaperon ◽  
F. LaGrone ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Drug Development ◽  
Phase I ◽  
Median Time ◽  
Ethical Issues ◽  
Phase 1 ◽  
Cancer Drug ◽  
Final Approval ◽  
Standard Language ◽  
Molecular Therapeutics

9080 Phase I oncology clinical trials are critical in the oncology drug development process. To protect human subjects, every phase 1 protocol must be approved by an institutional review board (IRB) to assure safety before patient accrual. As the volume and complexity of phase 1 trials have increased, the amount of time spent on IRB protocol reviews have also increased for various reasons. Objectives: 1) Determine the average time spent on protocol approval by IRB at KCI/WSU; 2) Identify potential issues raised by IRB resulting in approval delays; 3) Identify the redundancies for which “standard language” implementation could facilitate future IRB applications thereby expediting approval. Methods: 96 Phase 1 research IRB applications at KCI/WSU between 8/1/2005 and 10/31/2006 were reviewed. These applications were stratified based on submission (new protocol versus amendment) and IRB approval (tabled, provisional or approved) status. Concerns frequently brought up by the IRB were identified. Results: The average and median time spent from initial submission to final approval of all 96 applications were 41.4 days and 43 days, respectively. Forty eight of 96 applications (50%) were provisionally approved from the initial review. Average and median time of obtaining final approval were 52.5 days and 52 days. Nine of 96 (9.4%) protocols were tabled with their average approval 83 days. The most common concerns raised by IRB were risks/benefit issues. These concerns were an even greater approval barrier when protocols involved specialized technologies of molecular therapeutics or complicated study designs. Regulatory policy changes issued by oversight organizations also required “real-time” updates into protocols and consent form amendments. Areas of “standard language” for future IRB applications are being compiled and will be discussed upon presentation. Conclusion: Phase 1 clinical trials are essential to anti-cancer drug development. The complicated ethical issues and science warrant an ongoing constructive collaboration of both parties. Identification of commonalities that delay IRB approval will lead to more expeditious IRB approval not only at our institution, but could also benefit other institutions. No significant financial relationships to disclose.

Some Latin Inscriptions. I

1934 ◽  
Vol 3 (8) ◽  
pp. 113-117
Author(s):  
R. H. Barrow
Keyword(s):  
Final Approval ◽  
French Academy ◽  
Berlin Academy ◽  
The Mediterranean ◽  
The Way

One of the greatest historical achievements of the last century was the gathering together of the Latin inscriptions scattered over the various countries of Europe and the Mediterranean. The scheme was originated by Kellermann of Copenhagen (1805–37), who spent the last nine years of his life collecting inscriptions in Italy. It was taken up by members of the French Academy and finally carried through by the Berlin Academy. Many scholars, French, German, and Italian, had prepared the way by publishing collections of inscriptions; and the plan of the two scholars Zumpt, uncle and nephew, who were entrusted with the early preparations did not embrace much more than the rearranging of the published inscriptions. In 1847 a comprehensive scheme—the compilation of a corpus of inscriptions whether already published or not—was submitted to the Berlin Academy by Theodor Mommsen. In 1853 final approval was given and in 1863 appeared the first volume of the Corpus Inscriptionum Latinarum, consilio et auctoritate Academiae litterarum regiae Borussicae editum.

scholarly journals Neocuspidization of the aortic valve

2021 ◽  
Vol 25 (2) ◽  
pp. 11
Author(s):  
B. K. Kadyraliev ◽  
V. B. Arutyunyan ◽  
I. I. Chernov ◽  
A. H. Umarov ◽  
K. Yu. Zhigalov ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Conflict Of Interest ◽  
Low Cost ◽  
Long Term Results ◽  
Final Approval ◽  
Ideal Approach ◽  
Valve Reconstruction ◽  
Critical Revision ◽  
The Ideal

<p>Aortic valve reconstruction remains the ideal approach to treat aortic valve disease, with an aim to increase durability and prevent anticoagulation. Owing to its availability, handling ease, and low cost, autopericardium has been regularly used since the early days of cardiac surgery. Many of these methods have not been standardized yet and are underutilized. One method with promising long-term results is neocuspidization of the aortic valve, as described by Ozaki using glutaraldehyde-fixed autopericardium. Neocuspidization of the aortic valve includes valve prosthetics with its own pericardium. We performed a literature review on aortic valve neocuspidization.</p><p>Received 13 October 2020. Revised 6 November 2020. Accepted 11 November 2020.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Conception and study design: B.K. Kadyraliev, V.B. Arutyunyan, I.I. Chernov, A.H. Umarov, K.Yu. Zhigalov, A. Weymann, S.T. Enginoev<br />Drafting the article: B.K. Kadyraliev, V.B. Arutyunyan, S.T. Enginoev<br />Critical revision of the article: V.B. Arutyunyan, A.H. Umarov, S.T. Enginoev<br />Final approval of the version to be published: B.K. Kadyraliev, V.B. Arutyunyan, I.I. Chernov, A.H. Umarov, K.Yu. Zhigalov, <br />A. Weymann, S.T. Enginoev</p>

Sign in / Sign up

Export Citation Format

Share Document